塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/12 | 7,385 | 7,395 | 7,313 | 7,336 | -47 | -0.6% | 948,400 |
2024/04/11 | 7,250 | 7,391 | 7,250 | 7,383 | +44 | +0.6% | 705,800 |
2024/04/10 | 7,456 | 7,485 | 7,338 | 7,339 | -161 | -2.1% | 537,400 |
2024/04/09 | 7,560 | 7,580 | 7,484 | 7,500 | -28 | -0.4% | 519,400 |
2024/04/08 | 7,598 | 7,607 | 7,487 | 7,528 | -50 | -0.7% | 547,200 |
2024/04/05 | 7,550 | 7,592 | 7,474 | 7,578 | -12 | -0.2% | 716,800 |
2024/04/04 | 7,628 | 7,680 | 7,586 | 7,590 | +42 | +0.6% | 744,200 |
2024/04/03 | 7,488 | 7,589 | 7,401 | 7,548 | +24 | +0.3% | 973,200 |
2024/04/02 | 7,593 | 7,638 | 7,486 | 7,524 | -74 | -1% | 973,400 |
2024/04/01 | 7,795 | 7,824 | 7,569 | 7,598 | -152 | -2% | 511,000 |
2024/03/29 | 7,702 | 7,760 | 7,702 | 7,750 | +17 | +0.2% | 943,700 |
2024/03/28 | 7,758 | 7,818 | 7,711 | 7,733 | -112 | -1.4% | 888,900 |
2024/03/27 | 7,740 | 7,907 | 7,731 | 7,845 | +90 | +1.2% | 1,055,500 |
2024/03/26 | 7,751 | 7,788 | 7,731 | 7,755 | -57 | -0.7% | 860,000 |
2024/03/25 | 7,849 | 7,860 | 7,783 | 7,812 | -19 | -0.2% | 913,000 |
2024/03/22 | 7,837 | 7,879 | 7,800 | 7,831 | -21 | -0.3% | 850,600 |
2024/03/21 | 7,845 | 7,898 | 7,794 | 7,852 | +29 | +0.4% | 919,000 |
2024/03/19 | 7,806 | 7,844 | 7,768 | 7,823 | -18 | -0.2% | 720,800 |
2024/03/18 | 7,674 | 7,847 | 7,660 | 7,841 | +214 | +2.8% | 992,500 |
2024/03/15 | 7,667 | 7,803 | 7,544 | 7,627 | -187 | -2.4% | 2,285,100 |
2024/03/14 | 7,778 | 7,841 | 7,646 | 7,814 | -71 | -0.9% | 1,197,100 |
2024/03/13 | 7,788 | 7,885 | 7,766 | 7,885 | +106 | +1.4% | 1,128,300 |
2024/03/12 | 7,831 | 7,850 | 7,746 | 7,779 | -87 | -1.1% | 1,091,600 |
2024/03/11 | 7,883 | 7,951 | 7,763 | 7,866 | -48 | -0.6% | 1,360,600 |
2024/03/08 | 7,974 | 8,008 | 7,824 | 7,914 | -62 | -0.8% | 1,782,800 |
2024/03/07 | 7,998 | 8,137 | 7,970 | 7,976 | +75 | +0.9% | 1,932,400 |
2024/03/06 | 7,887 | 8,050 | 7,880 | 7,901 | +86 | +1.1% | 2,003,600 |
2024/03/05 | 7,800 | 7,865 | 7,718 | 7,815 | +97 | +1.3% | 1,690,800 |
2024/03/04 | 7,650 | 7,720 | 7,610 | 7,718 | +107 | +1.4% | 1,198,500 |
2024/03/01 | 7,449 | 7,638 | 7,397 | 7,611 | +127 | +1.7% | 1,563,800 |
2024/02/29 | 7,347 | 7,484 | 7,288 | 7,484 | +109 | +1.5% | 2,385,400 |
2024/02/28 | 7,390 | 7,457 | 7,344 | 7,375 | +17 | +0.2% | 1,100,300 |
2024/02/27 | 7,302 | 7,406 | 7,300 | 7,358 | +4 | +0.1% | 973,100 |
2024/02/26 | 7,190 | 7,363 | 7,170 | 7,354 | +207 | +2.9% | 1,891,200 |
2024/02/22 | 7,056 | 7,157 | 7,056 | 7,147 | +89 | +1.3% | 1,573,700 |
2024/02/21 | 7,065 | 7,142 | 7,043 | 7,058 | -86 | -1.2% | 1,020,100 |
2024/02/20 | 7,146 | 7,193 | 7,129 | 7,144 | +9 | +0.1% | 774,800 |
2024/02/19 | 7,103 | 7,140 | 7,064 | 7,135 | -17 | -0.2% | 795,600 |
2024/02/16 | 7,057 | 7,205 | 7,057 | 7,152 | +157 | +2.2% | 1,301,900 |
2024/02/15 | 7,114 | 7,133 | 6,941 | 6,995 | -102 | -1.4% | 1,030,900 |
2024/02/14 | 7,236 | 7,265 | 7,086 | 7,097 | -129 | -1.8% | 1,136,700 |
2024/02/13 | 7,273 | 7,273 | 7,174 | 7,226 | -26 | -0.4% | 1,278,900 |
2024/02/09 | 7,152 | 7,255 | 7,090 | 7,252 | +72 | +1% | 1,359,400 |
2024/02/08 | 7,100 | 7,215 | 7,084 | 7,180 | +131 | +1.9% | 1,431,500 |
2024/02/07 | 7,038 | 7,094 | 6,998 | 7,049 | +36 | +0.5% | 1,200,100 |
2024/02/06 | 7,028 | 7,066 | 6,949 | 7,013 | -20 | -0.3% | 958,900 |
2024/02/05 | 6,971 | 7,063 | 6,937 | 7,033 | +62 | +0.9% | 883,200 |
2024/02/02 | 7,132 | 7,169 | 6,971 | 6,971 | -147 | -2.1% | 1,277,800 |
2024/02/01 | 7,090 | 7,189 | 6,995 | 7,118 | +8 | +0.1% | 1,418,900 |
2024/01/31 | 7,060 | 7,200 | 7,015 | 7,110 | +47 | +0.7% | 1,639,300 |
151~
200
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 205,900円 | +5.7% | +3.9% | 2.78% | 10.24倍 | 1.35倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 895,200円 | +14.4% | +120.8% | 1.34% | 20.09倍 | 1.84倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 157,200円 | +12.2% | +180.3% | 4.71% | 56.28倍 | 1.84倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 461,900円 | +1.7% | -2.9% | 3.46% | 30.30倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 254,500円 | +11.3% | -5.4% | 2.28% | 19.59倍 | 1.54倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム